11 Results for "

PPARβ

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "PPARβ" in MCE Product Catalog:

18
18 Publications Verification
Cat. No.: HY-13928
CAS No.: 317318-84-6
Purity:  99.94%
Synonyms: GW610742
GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, 1.1 μM and 2 μM for human PPARδ, PPARα, and PPARγ, respectively.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-12377
CAS No.: 1014691-61-2
Purity:  99.49%
Target:  

PPAR

Research Areas:  

Metabolic Disease

GSK0660 is a potent PPARβ antagonist with an IC50 of 155 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N1029
CAS No.: 3542-72-1
Synonyms: Mangiferitin
Norathyriol (Mangiferitin) is a natural metabolite of Mangifera. Norathyriol inhibits α-glucosidase in a noncompetitive manner with an IC50 of 3.12 μM . Norathyriol inhibits PPARα, PPARβ, and PPARγ with IC50s of 92.8 µM, 102.4 µM, and 153.5 µM, respectively . Antioxidant, anticancer, antimicrobial, anti-inflammatory, anti-bacterial activities.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19383
CAS No.: 251303-04-5
Synonyms: PTP 112
Target:  

Phosphatase IKK PPAR

Research Areas:  

Metabolic Disease

Ertiprotafib is an inhibitor of PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist, with an IC50 of 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100277
CAS No.: 76541-72-5
Purity:  99.10%
Synonyms: SR-202
Target:  

PPAR

Research Areas:  

Metabolic Disease

Mifobate (SR-202) is a potent and specific PPARγ antagonist. Mifobate (SR-202) selectively inhibits Thiazolidinedione (TZD)-induced PPARγ transcriptional activity (IC50=140 μM). Mifobate (SR-202) does not affect basal or ligand-stimulated transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). Mifobate (SR-202) shows antiobesity and antidiabetic effects .
loading...
    loading...
Cat. No.: HY-108571
CAS No.: 702680-17-9
Purity:  98.70%
Target:  

PPAR

CP-775146 is a selective PPARα agonist (Ki of 24.5 nM) that binds strongly to the PPARα ligand. CP-775146 has no observable affinity for PPARβ and PPARγ.CP-775146 shows hypolipidemic activity. CP-775146 efficiently alleviates obesity-induced liver damage, prevents lipid accumulation by activating the liver fatty acid β-oxidation pathway .
loading...
    loading...
Cat. No.: HY-13928R
CAS No.: 317318-84-6
Synonyms: GW610742 (Standard)
GW0742 (Standard) is the analytical standard of GW0742. This product is intended for research and analytical applications. GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, 1.1 μM and 2 μM for human PPARδ, PPARα, and PPARγ, respectively.
loading...
    loading...
Cat. No.: HY-12377R
CAS No.: 1014691-61-2
Target:  

PPAR

Research Areas:  

Metabolic Disease

GSK0660 (Standard) is the analytical standard of GSK0660. This product is intended for research and analytical applications. GSK0660 is a potent PPARβ antagonist with an IC50 of 155 nM.
loading...
    loading...
Cat. No.: HY-101637
CAS No.: 170861-63-9
Synonyms: JT 501
Target:  

PPAR

Research Areas:  

Metabolic Disease

Reglitazar is an agonist for peroxisome proliferator-activated receptor α and β (PPAR α and PPAR β), which enhances insulin sensitivity, lowers blood glucose and regulates blood lipid levels .
loading...
    loading...
Cat. No.: HY-116699
CAS No.: 702681-67-2
Purity:  99.08%
CP-868388 free base is a potent, selective and orally active PPARα agonist with a Ki value of 10.8 nM. CP-868388 free base has little or no affinity for PPARβ (Ki of 3.47 μM) and PPARγ. CP-868388 free base has hypolipidemic and anti-inflammatory actions .
loading...
    loading...
Cat. No.: HY-100277R
CAS No.: 76541-72-5
Synonyms: SR-202 (Standard)
Research Areas:  

Metabolic Disease

Mifobate (Standard) is the analytical standard of Mifobate. This product is intended for research and analytical applications. Mifobate (SR-202) is a potent and specific PPARγ antagonist. Mifobate (SR-202) selectively inhibits Thiazolidinedione (TZD)-induced PPARγ transcriptional activity (IC50=140 μM). Mifobate (SR-202) does not affect basal or ligand-stimulated transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). Mifobate (SR-202) shows antiobesity and antidiabetic effects .
loading...
    loading...
  • 1